Patel Sujal M
SEC insider (Form 3/4/5 filer). CIK 0001378830. CEO, President, and Secretary at Nautilus Biotechnology, Inc. (NAUT). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in SEATTLE, WA.
Companies Patel Sujal M has filed insider reports for
- Nautilus Biotechnology, Inc. (NAUT): Director, Officer, 10% Owner, CEO, President, and Secretary
Patel Sujal M
CIK: 0001378830
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nautilus Biotechnology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Mar 4, 2026NAUT
Nautilus Biotechnology, Inc.
PurchaseDirect25K shares at avg. $2.61$65K - Mar 2, 2026NAUT
Nautilus Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
650K shares- - Sep 8, 2025NAUT
Nautilus Biotechnology, Inc.
PurchaseDirect83.5K shares at avg. $0.68$57K - Sep 5, 2025NAUT
Nautilus Biotechnology, Inc.
PurchaseDirect116.5K shares at avg. $0.67$79K - Mar 20, 2025NAUT
Nautilus Biotechnology, Inc.
PurchaseDirect23.9K shares at avg. $1.00$24K - Mar 19, 2025NAUT
Nautilus Biotechnology, Inc.
PurchaseDirect53.3K shares at avg. $0.99$53K - Mar 3, 2025NAUT
Nautilus Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
650K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 4, 2026 | NAUT Nautilus Biotechnology, Inc. | Purchase | 25,000 | $2.61 | $65,238 | Direct |
| Mar 2, 2026 | NAUT Nautilus Biotechnology, Inc. | Award Stock Option (Right to Buy) | 650,000 | - | - | Direct |
| Sep 8, 2025 | NAUT Nautilus Biotechnology, Inc. | Purchase | 83,500 | $0.68 | $57,031 | Direct |
| Sep 5, 2025 | NAUT Nautilus Biotechnology, Inc. | Purchase | 116,500 | $0.67 | $78,544 | Direct |
| Mar 20, 2025 | NAUT Nautilus Biotechnology, Inc. | Purchase | 23,933 | $1.00 | $23,890 | Direct |
| Mar 19, 2025 | NAUT Nautilus Biotechnology, Inc. | Purchase | 53,300 | $0.99 | $53,028 | Direct |
| Mar 3, 2025 | NAUT Nautilus Biotechnology, Inc. | Award Stock Option (Right to Buy) | 650,000 | - | - | Direct |
1-7 of 7 transactions